Clinical Trial Update: Assessment of the Safety, Efficacy, PK, and Extrapulmonary Pharmacodynamics (PD) of Albuterol Sulfate Pressurized Inhalation Suspension (Hereafter Referred to as AS MDI) Compared to Proventil as an Active Control in Subjects With Asthma [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety, efficacy, pharmacokinetics, and extrapulmonary pharmacodynamics of albuterol sulfate MDI compared to Proventil in asthma; study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Albuterol sulfate pressurized inhalation suspension (AS MDI) (albuterol sulfate)
• Proventil (albuterol)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2019-07-23